RxDoctor Payments Data

Mark Mounajjed, MD

Infectious Disease · Madison, WINPI 1891789897

Payments from drug & device makers

$134in general payments, 2019–2025

Across 3 payments — averaging $44.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$99
  • Merck$19
  • Insmed, Inc.$16

What the payments were for

  • Food & beverage$1914%
  • Education$11586%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Astellas Pharma US Inc1$99
Merck1$19
Insmed, Inc.1$16

How this compares

$134 in reported general payments places this provider in the 50th percentile of 133 infectious disease providers in Wisconsin.

See all infectious disease providers in Wisconsin

Medicare billing

Part B allowed, 2024
$556,419
Medicare patients
313
Services billed
40,966

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Vancomycin Hcl17$1,015
Cefadroxil13$766
CeftriaxoneCeftriaxone Sodium16$533
Ciprofloxacin Hcl14$423
Penicillin V Potassium18$259
Amoxicillin17$123

Paid to pharmacies, not to this prescriber.

Other infectious disease in Madison

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →